Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Adam N. Alghalith"'
Autor:
Rachael G. Aubin, Emma C. Troisi, Javier Montelongo, Adam N. Alghalith, Maclean P. Nasrallah, Mariarita Santi, Pablo G. Camara
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-14 (2022)
The molecular mechanisms underlying ependymoma tumorigenesis remain poorly understood. Here, single cell analysis of posterior fossa primary tumours and distal metastases highlights the role of pro-inflammatory cytokines in promoting epithelial-to-me
Externí odkaz:
https://doaj.org/article/5813a87138be474398527991ba01b4e8
Autor:
Raúl Rabadán, Yamina Mohamedi, Udi Rubin, Tim Chu, Adam N. Alghalith, Oliver Elliott, Luis Arnés, Santiago Cal, Álvaro J. Obaya, Arnold J. Levine, Pablo G. Cámara
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-10 (2020)
Rare cancer mutations are often missed using recurrence-based statistical approaches, but are usually accompanied by changes in expression. Here the authors leverage this information to uncover several elusive candidate cancer-associated genes using
Externí odkaz:
https://doaj.org/article/704bc0872a5c4264834902454745c986
Cell Ecosystem and Signaling Pathways of Primary and Metastatic Pediatric Posterior Fossa Ependymoma
Autor:
Emma C. Troisi, MacLean Nasrallah, Adam N. Alghalith, Pablo G. Camara, Rachael G. Aubin, Mariarita Santi
Pediatric ependymoma is a devastating brain cancer marked by its relapsing pattern and lack of effective chemotherapies. This shortage of treatments is partially due to limited knowledge about ependymoma tumorigenic mechanisms. Although there is evid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d97701ae00732732bd0087dbadd56bda
https://doi.org/10.1101/2020.08.10.244483
https://doi.org/10.1101/2020.08.10.244483
Autor:
Alvaro J. Obaya, Adam N. Alghalith, Oliver Elliott, Pablo G. Camara, Udi Rubin, Tim Chu, Luis Arnes, Raul Rabadan, Arnold J. Levine, Yamina Mohamedi, Santiago Cal
Publikováno v:
Scopus
RUO. Repositorio Institucional de la Universidad de Oviedo
Universidad de las Islas Baleares
Nature Communications, Vol 11, Iss 1, Pp 1-10 (2020)
RUO: Repositorio Institucional de la Universidad de Oviedo
Universidad de Oviedo (UNIOVI)
Nature Communications
RUO. Repositorio Institucional de la Universidad de Oviedo
Universidad de las Islas Baleares
Nature Communications, Vol 11, Iss 1, Pp 1-10 (2020)
RUO: Repositorio Institucional de la Universidad de Oviedo
Universidad de Oviedo (UNIOVI)
Nature Communications
Large-scale cancer genomic studies enable the systematic identification of mutations that lead to the genesis and progression of tumors, uncovering the underlying molecular mechanisms and potential therapies. While some such mutations are recurrently
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93c16db02376f2e975bee563cd353c43
http://hdl.handle.net/10651/57604
http://hdl.handle.net/10651/57604
Cell Ecosystem and Signaling Pathways of Primary and Metastatic Pediatric Posterior Fossa Ependymoma
Autor:
Pablo G. Camara, Mariarita Santi, Rachael G. Aubin, MacLean Nasrallah, Adam N. Alghalith, Emma C. Troisi
Publikováno v:
SSRN Electronic Journal.
Pediatric ependymoma is a devastating brain cancer marked by its relapsing pattern and lack of effective chemotherapies. This shortage of treatments is partially due to limited knowledge about ependymoma tumorigenic mechanisms. Although there is evid
Autor:
Rachael G. Aubin, Adam N. Alghalith, MacLean Nasrallah, Emma C. Troisi, Mariarita Santi, Pablo G. Camara
Publikováno v:
Neuro-Oncology
Childhood ependymoma is a cancer of the central nervous system with a chronic relapsing pattern. In children, 90% of ependymal tumors occur intracranially where prognosis is grim. Standard care for this disease includes surgical resection followed by
Autor:
Rachael G. Aubin, Adam N. Alghalith, Pablo G. Camara, Mariarita Santi, Emma C. Troisi, MacLean Nasrallah
Publikováno v:
Cancer Research. 80:PO-016
Childhood ependymoma is a cancer of the central nervous system marked by its relapsing pattern. Currently, there are no effective chemotherapies for this devastating disease and standard of care remains neurosurgery followed by radiation. The most pr